PT1763586E - Nova sequência para melhorar a expressão de ácido nucleico - Google Patents

Nova sequência para melhorar a expressão de ácido nucleico Download PDF

Info

Publication number
PT1763586E
PT1763586E PT05756870T PT05756870T PT1763586E PT 1763586 E PT1763586 E PT 1763586E PT 05756870 T PT05756870 T PT 05756870T PT 05756870 T PT05756870 T PT 05756870T PT 1763586 E PT1763586 E PT 1763586E
Authority
PT
Portugal
Prior art keywords
nucleic acid
improving expression
novel sequence
expression
repressor
Prior art date
Application number
PT05756870T
Other languages
English (en)
Portuguese (pt)
Inventor
Arie Pieter Otte
Theodorus Hendrikus Kwaks
Richard George Antonius Sewalt
Henricus Johannes Maria Van Blokland
Original Assignee
Chromagenics Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34971366&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PT1763586(E) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Chromagenics Bv filed Critical Chromagenics Bv
Publication of PT1763586E publication Critical patent/PT1763586E/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/67—General methods for enhancing the expression
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Chemistry (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PT05756870T 2004-07-08 2005-07-07 Nova sequência para melhorar a expressão de ácido nucleico PT1763586E (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US58700704P 2004-07-08 2004-07-08
EP2004051405 2004-07-08

Publications (1)

Publication Number Publication Date
PT1763586E true PT1763586E (pt) 2008-02-25

Family

ID=34971366

Family Applications (1)

Application Number Title Priority Date Filing Date
PT05756870T PT1763586E (pt) 2004-07-08 2005-07-07 Nova sequência para melhorar a expressão de ácido nucleico

Country Status (19)

Country Link
US (1) US7825232B2 (https=)
JP (1) JP4805262B2 (https=)
KR (1) KR101188013B1 (https=)
CN (1) CN1981057B (https=)
AT (1) ATE378426T1 (https=)
AU (1) AU2005261699B2 (https=)
BR (1) BRPI0512798A (https=)
CA (1) CA2573022C (https=)
DE (1) DE602005003369T2 (https=)
DK (1) DK1763586T3 (https=)
EA (1) EA011747B1 (https=)
ES (1) ES2296201T3 (https=)
IL (1) IL180531A (https=)
MX (1) MXPA06014553A (https=)
NO (1) NO341862B1 (https=)
NZ (1) NZ551510A (https=)
PT (1) PT1763586E (https=)
WO (1) WO2006005718A2 (https=)
ZA (1) ZA200610470B (https=)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE354645T1 (de) 2002-12-20 2007-03-15 Chromagenics Bv Mittel und methoden zur produktion eines proteins durch chromatin-öffner, die chromatin zugänglicher für transkriptionsfaktoren machen können
US20060172382A1 (en) * 2004-11-08 2006-08-03 Chromagenics B.V. Selection of host cells expressing protein at high levels
US20060195935A1 (en) 2004-11-08 2006-08-31 Chromagenics B.V. Selection of host cells expressing protein at high levels
US20100136616A1 (en) * 2004-11-08 2010-06-03 Chromagenics B.V. Selection of Host Cells Expressing Protein at High Levels
US8999667B2 (en) * 2004-11-08 2015-04-07 Chromagenics B.V. Selection of host cells expressing protein at high levels
EP1809750B1 (en) * 2004-11-08 2012-03-21 ChromaGenics B.V. Selection of host cells expressing protein at high levels
US8039230B2 (en) 2004-11-08 2011-10-18 Chromagenics B.V. Selection of host cells expressing protein at high levels
EP2443239B1 (en) 2009-06-15 2015-11-25 Cellagenics B.V. Novel stringent selectable markers
CN103038352B (zh) 2010-06-15 2015-12-16 萨拉基尼克有限公司 用于增强基因表达的新型基因间元件
CN103180443B (zh) 2010-09-01 2016-01-13 萨拉基尼克有限公司 用于增强基因表达的来自核糖体蛋白启动子的核酸片段
CN110484563B (zh) * 2019-07-25 2023-04-07 新乡医学院 哺乳动物细胞组合表达载体、表达系统、制备方法和应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE466941T1 (de) * 2001-07-04 2010-05-15 Chromagenics Bv Dns-sequenzen mit anti-repressor-aktivität
CA2489475C (en) * 2002-06-14 2011-03-29 Chromagenics B.V. A method for simultaneous production of multiple proteins; vectors and cells for use therein
ATE354645T1 (de) * 2002-12-20 2007-03-15 Chromagenics Bv Mittel und methoden zur produktion eines proteins durch chromatin-öffner, die chromatin zugänglicher für transkriptionsfaktoren machen können

Also Published As

Publication number Publication date
ATE378426T1 (de) 2007-11-15
WO2006005718A3 (en) 2006-08-17
MXPA06014553A (es) 2007-03-12
CN1981057B (zh) 2012-07-04
IL180531A0 (en) 2007-06-03
WO2006005718A2 (en) 2006-01-19
DE602005003369T2 (de) 2009-03-05
NO341862B1 (no) 2018-02-12
EA011747B1 (ru) 2009-06-30
CA2573022A1 (en) 2006-01-19
EA200700233A1 (ru) 2007-06-29
AU2005261699B2 (en) 2009-07-23
CA2573022C (en) 2012-03-06
BRPI0512798A (pt) 2008-04-08
HK1097004A1 (en) 2007-06-15
JP2008505626A (ja) 2008-02-28
US20070212755A1 (en) 2007-09-13
AU2005261699A1 (en) 2006-01-19
ZA200610470B (en) 2008-09-25
US7825232B2 (en) 2010-11-02
KR101188013B1 (ko) 2012-10-08
CN1981057A (zh) 2007-06-13
DE602005003369D1 (de) 2007-12-27
DK1763586T3 (da) 2008-03-17
ES2296201T3 (es) 2008-04-16
KR20070042122A (ko) 2007-04-20
IL180531A (en) 2011-04-28
NZ551510A (en) 2009-10-30
JP4805262B2 (ja) 2011-11-02
NO20070757L (no) 2007-02-08

Similar Documents

Publication Publication Date Title
NO20070757L (no) Ny sekvens for forbedring av ekspresjon av nukleinsyre(r)
EP2298872A3 (en) Polypeptides having lipase activity and polynucleotides encoding same
WO2007019442A3 (en) Polypeptides having beta-glucosidase activity and polynucleotides encoding same
IL236427A (en) Isolated amino acids, vectors, host cells, and antibody preparation methods il-23p19
WO2005074647A3 (en) Polypeptides having cellulolytic enhancing activity and polynucleotides encoding same
WO2006073839A3 (en) Acid fungal proteases
WO2005074656A3 (en) Polypeptides having cellulolytic enhancing activity and polynucleotides encoding same
WO2003089598A3 (en) Polypeptides having xyloglucanase activity and nucleic acids encoding same
WO2006074435A3 (en) Polypeptides having cellobiohydrlase activity and polynucleotides encoding same
WO2005084305A3 (en) Flavonoids
AU2003291962A1 (en) Polypeptides having cellobiohydrolase ii activity and polynucleotides encoding same
WO2006047469A8 (en) Polypeptides having lipase activity and polynucleotides encoding same
TW200740841A (en) Polypeptides having antimicrobial activity and polynucleotides encoding same
AU2003238717A1 (en) POLYPEPTIDES HAVING Alpha- H-Alpha-AMINO ACID AMIDE RACEMASE ACTIVITY AND NUCLEIC ACIDS ENCODING THE SAME
TW200510460A (en) Antimicrobial polypeptides
ATE488591T1 (de) Neuer l-lysin-induzierbarer promotor
TW200621284A (en) Polypeptides having antimicrobial activity and polynucleotides encoding same
WO2006005032A3 (en) Polypeptides having alpha-glucosidase activity and polynucleotides encoding same
WO2006076628A3 (en) Compositions comprising promoter sequences and methods of use
TW200502253A (en) Antimicrobial polypeptides
TW200734350A (en) Polypeptides having antimicrobial activity and polynucleotides encoding same
WO2008002548A3 (en) Novel human acidic mammalian chitinase and use thereof
WO2006014490A3 (en) Polypeptides having alpha-glucosidase activity and polynucleotides encoding same
TW200621285A (en) Polypeptides having antimicrobial activity and polyncleotides encoding same
WO2004065554A3 (en) Human saa3 nucleic acid molecule, protein, and methods of use for same